NO955056L - Enantiomerer av 4-(5-fluor-2,3-dihydro-1H-inden-2-yl)-1H-imidazol - Google Patents

Enantiomerer av 4-(5-fluor-2,3-dihydro-1H-inden-2-yl)-1H-imidazol

Info

Publication number
NO955056L
NO955056L NO955056A NO955056A NO955056L NO 955056 L NO955056 L NO 955056L NO 955056 A NO955056 A NO 955056A NO 955056 A NO955056 A NO 955056A NO 955056 L NO955056 L NO 955056L
Authority
NO
Norway
Prior art keywords
inden
dihydro
imidazole
fluoro
enantiomers
Prior art date
Application number
NO955056A
Other languages
English (en)
Other versions
NO955056D0 (no
Inventor
Arto Johannes Karjalainen
Raimo Einari Virtanen
Arja Leena Karjalainen
Seppo Sulevi Lennart Parhi
Maire Marjatta Eloranta
Antti Sakari Haapalinna
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NO955056L publication Critical patent/NO955056L/no
Publication of NO955056D0 publication Critical patent/NO955056D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Optiske isomerer av 4-(5-fluor-2,3-dihydro-lH- inden-2-yl)-lH-imidazol og farmasøytisk akseptable salter derav, deres anvendelse og fremstilling er beskrevet. Begge isomerer er virksomme i behand- ling av kognitive sykdommer.
NO955056A 1993-06-18 1995-12-13 Enantiomerer av 4-(5-fluor-2,3-dihydro-1H-inden-2-yl)-1H-imidazol NO955056D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939312669A GB9312669D0 (en) 1993-06-18 1993-06-18 New opticla isomers
PCT/FI1994/000263 WO1995000492A1 (en) 1993-06-18 1994-06-16 Enantiomers of 4-(5-fluoro-2,3-dihydro-1h-inden-2-yl)-1h-imidazole

Publications (2)

Publication Number Publication Date
NO955056L true NO955056L (no) 1995-12-13
NO955056D0 NO955056D0 (no) 1995-12-13

Family

ID=10737432

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955056A NO955056D0 (no) 1993-06-18 1995-12-13 Enantiomerer av 4-(5-fluor-2,3-dihydro-1H-inden-2-yl)-1H-imidazol

Country Status (19)

Country Link
EP (1) EP0703903A1 (no)
JP (1) JPH08511554A (no)
CN (1) CN1125439A (no)
AU (1) AU6972594A (no)
BG (1) BG100218A (no)
CA (1) CA2165459A1 (no)
CZ (1) CZ332195A3 (no)
EE (1) EE9400010A (no)
GB (1) GB9312669D0 (no)
HU (1) HU211271A9 (no)
IL (1) IL109984A0 (no)
LT (1) LT3468B (no)
LV (1) LV11462B (no)
NO (1) NO955056D0 (no)
NZ (1) NZ267427A (no)
PL (1) PL312194A1 (no)
SK (1) SK157095A3 (no)
WO (1) WO1995000492A1 (no)
ZA (1) ZA944346B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
FR2839719B1 (fr) * 2002-05-16 2004-08-06 Pf Medicament Nouveaux composes imidazoliques, leur procede de preparation et leur utilisation a titre de medicaments
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2167408B (en) 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
FI81092C (fi) 1986-05-15 1990-09-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
GB2225782A (en) 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB2244431A (en) 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
ZA944346B (en) 1995-02-15
EP0703903A1 (en) 1996-04-03
AU6972594A (en) 1995-01-17
NO955056D0 (no) 1995-12-13
BG100218A (bg) 1996-06-28
LV11462B (en) 1996-12-20
CZ332195A3 (en) 1996-05-15
IL109984A0 (en) 1994-12-29
EE9400010A (et) 1995-12-15
PL312194A1 (en) 1996-04-01
CA2165459A1 (en) 1995-01-05
LT3468B (en) 1995-10-25
GB9312669D0 (en) 1993-08-04
SK157095A3 (en) 1996-06-05
NZ267427A (en) 1996-10-28
LTIP1959A (en) 1995-01-31
JPH08511554A (ja) 1996-12-03
HU211271A9 (en) 1995-11-28
CN1125439A (zh) 1996-06-26
WO1995000492A1 (en) 1995-01-05
LV11462A (lv) 1996-08-20

Similar Documents

Publication Publication Date Title
PT831910E (pt) Terapia de combinacao a base de um antagonista epoxi-esteroidal de aldosterona e um antagonista de angiotensina ii para o tratamento de ataque cardiaco congestivo
CY1115759T1 (el) Αντιβιοτικες συνθεσεις για θεραπεια του οφθαλμου
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
DE69108048D1 (de) Derivate von hydroxaminsäure und von n-hydroxyharnstoff sowie ihre verwendung.
TR199802296T2 (xx) Yeni 2,3 dis�bstit�te-4 (3H)-kinazolinonlar
SE9504661D0 (sv) New compounds
ATE206708T1 (de) Benzimidazolonderivate mit zentraler dopaminerger aktivität
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
SE9802208D0 (sv) Novel compounds
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
MX9709910A (es) Compuestos que contienen arginina e imitaciones de arginina, su uso y composiciones que los contienen.
DE69530988D1 (de) Benzimidazolderivate mit dopaminerger wirkung
NO955056L (no) Enantiomerer av 4-(5-fluor-2,3-dihydro-1H-inden-2-yl)-1H-imidazol
RS50129B (sr) Optički aktivan derivat piridil-4h-1,2,4-oksadiazina i njegova upotreba u proizvodnji lekova za tretiranje vaskularnih bolesti
FR2733995B1 (fr) Inhibiteurs de l'inactivation de neuropeptides endogenes notamment la cholecystokinine, leurs procedes de preparation leur utilisation comme medicaments et procede de criblage de medicaments
SE9802209D0 (sv) Novel compounds
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
SE9504662D0 (sv) New compounds
SE9802538D0 (sv) New pharmaceutically active compounds
PT1232173E (pt) Derivados do acido fusidico
DE3865675D1 (de) 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl)-1h-imidazol.
NO982349L (no) Nye kinoksalindionderivater, deres fremstilling og anvendelse i legemidler
AU5870298A (en) 1,4-dihydropyridin derivatives and their use in therapy
NO963869L (no) Behandling av diabetisk nefropati med valsartan